On Apr. 20, 2021, the University of Oxford, Prenetics, and Oxford Suzhou Centre for Advanced Research announced that they had signed collaboration agreements to further develop the award-winning OxLAMPTM technology, a rapid, molecular testing technology for infectious diseases.

The first OxLAMPTM RaViD Direct SARS-CoV-2 product was developed to help global communities world-wide with rapid, portable, accurate results for the detection of COVID-19.